I still like Home Depot for the long run. Its 7% gain since having been suggested a couple of months ago wouldn’t keep me from buying more if I didn’t already have a nice chunk — but for the long term. I have no idea where it, or the market, will be in a six months.
Meanwhile, a stock Guru and I recently paid as much as $20.70 for last month — AKBA — can now be yours for about half the price. Of course, if it goes to zero, you will lose the same 100% we do. But Guru thinks “It should be in the 30s or 40s. It’s the wave of the future of anemia management and although it’s behind Fibrogen, it has a drug that looks structurally similar, certainly works well, and didn’t kill anyone. No question: it’s a medical breakthrough.” If it did ever hit $40, you’d have nearly a quadruple while, on the first shares I bought, I’d have only a double. I hate you.
PASS THE SALT
JOIN THE MOVEMENT
“Cynicism is a choice. Hope is a better choice.” — Barack Obama
Quote of the Day
The subjects of every state ought to contribute towards the support of the government, as nearly as possible, in proportion to their respective abilities; that is, in proportion to the revenue which they respectively enjoy under the protection of the state.~Adam Smith, The Wealth Of Nations
Request email delivery
- Feb 15:
NYC. UK. Canada.
- Feb 14:
If Republican Officials Go To Prison . . .
- Feb 13:
The National Butterfly Center Is Taking A Stand
- Feb 12:
Home-Schooled For Christ. And Pence.
- Feb 11:
Russian TV Thanks The GOP (And Don’t Miss Bill Maher)
- Feb 9:
The Perfect Virginia Solution
- Feb 8:
The Case For A Better Wealth Tax
- Feb 7:
200 Times More Interest On Your Money . . .
- Feb 6:
Listen To A Structural Forensicist
- Feb 5:
Tom Brady’s Secret For Your Parents
- Feb 15: